Papillomavirus vaccine looking positive after Phase I
14 August, 2002 by Pete YoungPromising results have emerged from a two-year Phase I human clinical trial of an Australian-developed therapeutic vaccine targeting cervical cancer.
Cell death key discovered by Monash Institute
07 August, 2002 by Tanya HollisMelbourne researchers have uncovered a new genetic player in programmed cell death, offering a fresh target for potential cancer therapies.
Monash researchers in osteoporosis find
06 August, 2002 by Tanya HollisAn international collaboration including Melbourne researchers has uncovered two reasons for calcium deposits in bones and joints, setting the foundation for new osteoporosis therapies.
Starpharma gains new US patent approval
05 August, 2002 by Tanya HollisNanotechnology drug developer Starpharma Pooled Development today announced it had gained approval for a United States patent over its dendrimer-based anti-cancer products.
pSivida in joint venture with Singapore hospital
30 July, 2002 by Pete YoungThe first joint venture equity pact struck by Singapore's largest hospital could open a fast track to market for anti-cancer technology from Perth biotech pSivida.
Novogen subsidiary signs with NIH agency for cancer trials
25 July, 2002 by Tanya HollisMarshall Edwards Inc, a listed subsidiary of Australian pharma Novogen, has signed a cooperative agreement with a National Institutes of Health agency in the United States to examine clinical applications for its anti-cancer compound, phenoxodiol.
Making things better
24 July, 2002 by Tanya HollisProf Bob Williamson's involvement in genetics goes back to a time when few people understood the possibilities of the science.
New UQ research complex
17 July, 2002 by Melissa TrudingerA new research complex, the Centres for Health Research, was officially opened on Monday at the Princess Alexandra Hospital to house 140 scientists from the University of Queensland and the Princess Alexandra Hospital.
CBio bucks trend, achieves 'satisfactory' capital raising
17 July, 2002 by Pete YoungBrisbane biotech CBio is set to conclude an 11-month, $5 million capital raising that coincided with the worst investor environment in a decade.
Diabetes feature: the politics of diabetes
15 July, 2002 by Tanya HollisAs well as the many clinical research projects looking for cures and better treatments, a major emphasis in stemming the level of adult-onset diabetes in Australia lies in education and awareness.
Diabetes feature
15 July, 2002 by Tanya HollisAttend any major meeting on diabetes around the world and chances are there will be a fair contingent of Aussies in attendance. Australian researchers are renowned for their work in all facets of the disease, which experts say has now burgeoned to epidemic proportions.
Skin cancer prevention treatment developed at Uni of SA
11 July, 2002 by Melissa TrudingerScientists at the University of South Australia's Centre for Pharmaceutical Research have developed a topical treatment that could be used to prevent skin cancers from developing in susceptible people.
Prima meets cancer milestones
10 July, 2002 by Tanya HollisDrug development company Prima Biomed has told the market its first year research programs into cancer immunotherapy and anti-inflammatory treatments had met or exceeded their milestones.
Researchers welcome xenotransplantation guidelines
09 July, 2002 by Staff WritersAustralian researchers have welcomed the National Health and Medical Research Council's draft guidelines on xenotransplantation, released yesterday.
NHMRC gives cautious nod to xenotransplantation
08 July, 2002 by Iain ScottA working party of the National Health and Medical Research Council has offered its tentative approval of research involving the transplantation of cells from animals to humans.
